Willis Towers Watson (WTW)
(Delayed Data from NSDQ)
$263.13 USD
-3.51 (-1.32%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $263.24 +0.11 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$263.13 USD
-3.51 (-1.32%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $263.24 +0.11 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Zacks News
Aon (AON) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Aon (AON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Willis Towers Watson (WTW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Willis Towers Watson (WTW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Towers Watson and Brown & Brown
by Zacks Equity Research
Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Towers Watson and Brown & Brown have been highlighted in this Industry Outlook article.
5 Insurance Brokerage Picks to Gain From Increased Demand
by Sushmita Sarker
The increased demand for insurance products, given an aging population, baby boomers and millennials, and accelerated digitization, should drive insurance brokers like MMC, AON, AJG, WTW and BRO.
Should You Buy Marsh & McLennan (MMC) Following Dividend Hike?
by Zacks Equity Research
This increase reflects Marsh & McLennan's (MMC) 14th consecutive year of dividend increases and underscores its commitment to returning capital to shareholders.
Here's Why Willis Towers (WTW) Stock is Worth Retaining
by Zacks Equity Research
New business, strategic acquisitions, geographic diversification, solid customer retention levels and a strong capital position poise Willis Towers (WTW) for growth.
Here's Why Investors Should Retain Willis Towers (WTW) Now
by Zacks Equity Research
Willis Towers (WTW) stands to gain from growth across the global lines of business, strategic inorganic expansion, higher demand for products and advisory work and a solid balance sheet.
The Zacks Analyst Blog Highlights JPMorgan Chase, Texas Instruments, Morgan Stanley, Ross Stores and Willis Towers Watson
by Zacks Equity Research
JPMorgan Chase, Texas Instruments, Morgan Stanley, Ross Stores and Willis Towers Watson are included in this Analyst Blog.
Top Research Reports for JPMorgan Chase, Texas Instruments & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Texas Instruments Incorporated (TXN) and Morgan Stanley (MS).
Arthur J. Gallagher (AJG) Q1 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q1 results reflect higher adjusted revenues and adjusted EBITDAC across the Brokerage and Risk Management segments, partially offset by higher expenses.
Willis Towers (WTW) Q1 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Willis Towers (WTW) Q1 results reflect solid performance of Health, Wealth & Career and Risk & Broking segments, as well as improved adjusted operating income, offset by higher expenses.
Willis Towers Watson (WTW) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Willis Towers Watson (WTW) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Towers Watson and Brown and Brown
by Zacks Equity Research
Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Towers Watson and Brown and Brown are part of the Zacks Industry Outlook article.
Watch These 5 Insurance Stocks for Q1 Earnings: Beat or Miss?
by Tanuka De
Insurers like AJG, WTW, HIG, CINF and KNSL are due to report first-quarter 2024 earnings tomorrow. Let's see what's in store for them.
5 Stocks From the Thriving Insurance Brokerage Industry
by Sushmita Sarker
The increased demand for insurance products, given an aging population, baby boomers and millennials, and accelerated digitization, should drive insurance brokers like MMC, AON, AJG, WTW and BRO.
How to Play AON Ahead of Q1 Earnings? Will Higher Costs Shock?
by Zacks Equity Research
AON's first-quarter results are likely to showcase a significant increase in Health Solutions revenues.
Unveiling Willis Towers Watson (WTW) Q1 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Willis Towers Watson (WTW), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Will Willis Towers' (WTW) Beat Streak Continue in Q1 Earnings?
by Zacks Equity Research
Willis Towers' (WTW) first-quarter performance is likely to have benefited from increased project revenues, rate increases, higher compensation survey sales and strong new business.
Aon (AON) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Aon (AON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan (MMC) Q1 Earnings Beat on Strong EMEA Unit
by Zacks Equity Research
Marsh & McLennan's (MMC) first-quarter results benefit on the back of solid Marsh business and higher revenues derived from Health and Wealth businesses, partly offset by higher compensation and benefits expenses.
Willis Towers Watson (WTW) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Willis Towers Watson (WTW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Why Is Willis Towers Watson (WTW) Up 1.1% Since Last Earnings Report?
by Zacks Equity Research
Willis Towers Watson (WTW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Willis Towers Watson (WTW) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Willis Towers Watson (WTW) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE